Release Date: 22/11/13 09:07 Summary: Bidder's Statement - Off market bid Price Sensitive: No Download Document 1.24MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%